Vaccination ( 4719 results )
Semaine européenne de la vaccination 2026
- conference presentation
(Updated on )
Modeling the Risk of Hepatitis A Virus Transmission Through Blood Transfusion
- conference presentation
(Updated on )
Hepatitis B in France: Epidemiological Aspects and Vaccination Strategy. 24th National Continuing Education Conference on Hepatology and Gastroenterology, Paris, March 18–19, 2006
- article
(Updated on )
Surveillance of markers for HIV, HTLV, and hepatitis B and C virus infection among blood donors in France from 1991 to 2000
- article
(Updated on )
Monitoring of markers for HIV, HTLV, and hepatitis B and C virus infection among blood donors in France
- article
(Updated on )
Screening for markers of HIV, HTLV, and hepatitis B and C infections among blood donors in France
- article
(Updated on )
Epidemiological surveillance of homologous blood donors and residual risk in France between 2003 and 2005. Regular surveillance reports - Infectious diseases
Introduction - The national epidemiological surveillance of blood donors aims to monitor the prevalence and incidence of bloodborne infections (HIV, HTLV, HCV, and HBV), identify risk...
- report/summary
(Updated on )
Epidemiological surveillance of allogeneic blood donors in France between 1992 and 2002
Epidemiological surveillance of blood donors began in France in 1985 with the introduction of mandatory HIV screening for blood donations. The purpose of this report is to present all...
- article
(Updated on )
Prevalence of hepatitis B and C viruses, HIV, and HTLV among candidates for scheduled autologous transfusions in France, 1993–2000
Epidemiological surveillance of candidates for autologous transfusion was established in France in 1993. The number of candidates increased steadily between 1993 and 1997 and then...
(Updated on )
Epidemiological surveillance of allogeneic blood donors in France between 2001 and 2003. National Surveillance of Infectious Diseases, 2001–2003
Key points: - Prevalence rates remained stable over the 2001–2003 period: 0.60 per 104 new donors for HIV, 8.0 per 104 for HCV, 1.8 per 104 for HBsAg, and 0.56 per 104 for HTLV. -...
- article
(Updated on )
Epidemiological surveillance of homologous blood donors and residual risk in France between 2001 and 2003
National epidemiological surveillance of blood donors is conducted by the French Institute for Public Health Surveillance (InVS) and the National Reference Center (CNR) for Hepatitis B...
